Broad COVID-19 vaccination proves economically beneficial, especially for older adults, highlighting significant health and financial advantages. There are substantial economic benefits of broad COVID ...
Hosted on MSN
Pneumonia vaccines for adults are now recommended starting at age 50 – a geriatrician explains the change
Autumn brings a chill in the air – and the start of another season of respiratory illnesses, which can be especially hard for older adults. Although vaccine recommendations have been in flux, the ...
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 ...
Tony Wood, Chief Scientific Officer, GSK: “We are pleased with ACIP's recommendation to expand the benefits of RSV immunization to more than 13 million adults aged 50-59 who are at increased risk for ...
Nirmatrelvir-ritonavir reduced the risk for long COVID in adults aged 50 years and older but not in adolescents.
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Laurie Archbald-Pannone, University of Virginia (THE CONVERSATION) Autumn brings a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback